These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 15195634

  • 1. Research profile. Is there a link? TZDs and congestive heart failure. Andrew Karter, PhD.
    Kordella T.
    Diabetes Forecast; 2004 Jun; 57(6):98-100. PubMed ID: 15195634
    [No Abstract] [Full Text] [Related]

  • 2. [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].
    De Flines J, Scheen AJ.
    Rev Med Suisse; 2007 Aug 29; 3(122):1876, 1878-83. PubMed ID: 17896661
    [Abstract] [Full Text] [Related]

  • 3. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
    Buckingham RE, Hanna A.
    Diabetes Obes Metab; 2008 Apr 29; 10(4):312-28. PubMed ID: 18333890
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?
    Baskin S, Neher JO, Dodson S, Hoffman R.
    J Fam Pract; 2005 Aug 29; 54(8):723-4. PubMed ID: 16061064
    [No Abstract] [Full Text] [Related]

  • 8. The value equation for rosiglitazone and pioglitazone in older persons.
    Zarowitz BJ.
    Geriatr Nurs; 2008 Aug 29; 29(1):9-11. PubMed ID: 18267172
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?
    Patel C, Wyne KL, McGuire DK.
    Diab Vasc Dis Res; 2005 May 29; 2(2):61-6. PubMed ID: 16305060
    [Abstract] [Full Text] [Related]

  • 14. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U, Pop-Busui R, Eagle KA.
    Ann Pharmacother; 2008 Oct 29; 42(10):1466-74. PubMed ID: 18698014
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure.
    Erdmann E, Wilcox RG.
    Eur Heart J; 2008 Jan 29; 29(1):12-20. PubMed ID: 18167366
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone: failure of oversight or demons imagined?
    Susman J.
    J Fam Pract; 2007 Sep 29; 56(9):696, 703. PubMed ID: 17764640
    [No Abstract] [Full Text] [Related]

  • 19. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.
    Lago RM, Singh PP, Nesto RW.
    Lancet; 2007 Sep 29; 370(9593):1129-36. PubMed ID: 17905165
    [Abstract] [Full Text] [Related]

  • 20. Pioglitazone-induced heart failure despite normal left ventricular function.
    Shah M, Kolandaivelu A, Fearon WF.
    Am J Med; 2004 Dec 15; 117(12):973-4. PubMed ID: 15629744
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.